The ECB-IBS 2020 Congress has been moved to the 9-12 May 2021 and will still be held at the MECC in Maastricht, The Netherlands.
In 2020, the International Biotechnology Symposium Congress will be jointly organized with ECB2020, the Congress of European Federation of Biotechnology and with NBC-20, the annual Netherlands Biotechnology Conference, in Maastricht.
Though small in surface area, the Netherlands is a major player in biotechnology. Its success is based on a strong academic backbone, an entrepreneurial spirit, a remarkable talent to get things organized and a natural ability to cooperate. Maastricht lies at the heart of a region of 4 million people from four countries and in direct access to neighboring biotechnology activities in Belgium, Germany and France.
The joint IBS2020, ECB2020 and NBC-20 will showcase frontline science that will form the basis for future commercial innovation. The scientific program reveals an excellent line-up of plenary lectures and invited speakers. In line with the IBS and ECB tradition, the participation of young scientists will be promoted by encouraging them to submit original work to be considered for presentation as short talks or posters.
Production of biologicals | Genome editing | Bioengineering | Biocatalysis & metabolic engineering | Biotechnology for the environment and energy | Grand challenges for biotechnology
Program Committee co-chairs:
Richard van Kranenburg Co-Chair, Corbion
Aldrik Velders Co-Chair, Wageningen University
E-mail: email@example.com | Phone: +44 (0)207 808 5609